Applications of immune system tolerance to treatment of various diseases

• US 20010053362A1
• Filed: 03/09/2001
• Published: 12/20/2001
• Est. Priority Date: 03/09/2000
• Status: Abandoned Application

• Current Assignee: Lee Walters
• Original Assignee: Lee Walters
• Inventors: Walters, Lee
• Application Number:
  US09/802,350
• Publication Number:
  US 20010053362A1
• Time in Patent Office: Days
• US Class Current: 424/184.1
• CPC Class Codes: A61K 2035/124 the cells being hematopoietic, bone marrow derived or blood cells
• CPC Class Codes: A61K 2039/545 characterised by the dose, timing or administration schedule
• CPC Class Codes: A61K 39/001 Preparations to induce tolerance to non-self, e.g. prior to transplantation
• CPC Class Codes: A61P 37/02 Immunomodulators

Abstract

A new approach to immune system transplantation and other organ transplantation is described below. The invention describes the novel use of human tissues, or products derived from human tissues including but not limited to antigens, proteins, glycoproteins, and carbohydrates, taken from an individual patient, group or group of patients, to induce immunological tolerance to human antigens in other mammals. Mammals thus rendered tolerant to human antigens can subsequently serve as immune system donors, and as donors of other biological systems, to recipient humans. The invention also uniquely integrates experimentally documented observations from diverse fields of biological and medical research. The invention provides novel treatments for all cancers; for hereditary and acquired immunodeficiency disorders including AIDS; for failures of host immunological defenses including infectious diseases; for hereditary end acquired bone marrow failure syndromes; and for autoimmune diseases. In addition, the invention provides a novel method for achieving successful organ transplantation in humans, without graft rejection or graft-versus-host disease.

Claims

1. A method for reconstituting a subject'"'"'s immune system, said method comprising tolerizing the immune system of a non-human animal with antigens from said subject, and thereafter transplanting the bone marrow of said subject with the bone marrow of said tolerized immune system.